Cargando…
Leukaemias and cancers following iodine-131 administration for thyroid cancer.
We studied 1771 patients treated for a thyroid cancer in two institutions. None of these patients had been treated with external radiotherapy and 1497 had received (131)I. The average (131)I cumulative activity administered was 7.2 GBq, and the estimated average dose was 0.34 Sv to the bone marrow a...
Autores principales: | de Vathaire, F., Schlumberger, M., Delisle, M. J., Francese, C., Challeton, C., de la Genardiére, E., Meunier, F., Parmentier, C., Hill, C., Sancho-Garnier, H. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group|1
1997
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2063327/ https://www.ncbi.nlm.nih.gov/pubmed/9043033 |
Ejemplares similares
-
Leukaemia mortality in French communes (administrative units) with a large and rapid population increase.
por: Laplanche, A., et al.
Publicado: (1994) -
Iodine-131 and Thyroid Function
por: Sun, Wenjie
Publicado: (2014) -
Clinical experience following implementation of routine SPECT-CT imaging following 131-iodine administration for thyroid cancer
por: Ahmadi, Sara, et al.
Publicado: (2022) -
Selective venous sampling catheterisation for localisation of persisting medullary thyroid carcinoma.
por: Abdelmoumene, N., et al.
Publicado: (1994) -
Resveratrol Sensitizes Selectively Thyroid Cancer Cell to 131-Iodine Toxicity
por: Hosseinimehr, Seyed Jalal, et al.
Publicado: (2014)